XTI Aerospace, Inc. faces securities litigation over allegations that undisclosed activities by senior executives required Board review, exposed weaknesses in disclosure controls and contributed to the company’s inability to timely file its Form 10-Q. The allegations concern securities purchased between April 15 and Aug. 17, 2026, and follow XTI’s disclosure that it was reviewing its former Chief Executive Officer and related corporate governance matters. XTI shares fell $0.25, or 15.92%, to close at $1.32 on Aug. 18. Rosen Law Firm reminded investors that Oct. 27, 2026, is the deadline to seek appointment as lead plaintiff and said investors may pursue the case without upfront fees under a contingency arrangement. Pomerantz previously announced the class action, while Kuehn Law separately said it was investigating potential fiduciary-duty and disclosure breaches. No class has been certified, and investors may retain counsel, seek lead-plaintiff status or remain absent class members.